The birth-rate collapse isn’t just about money, housing, or women choosing careers. The sharper diagnosis: fewer couples. Across the world, young people still say they want kids. But they socialize less, partner less, commit less – and become parents less. Smartphones didn’t make us infertile. They may have made us lonelier. The fertility crisis is really a bonding crisis. https://t.co/DSi1emv0HU
We can say it again - prostate MRI is highly informative when positive, but it is not very informative and often misleading when negative. MRI is simply NOT a reliable rule out test in most settings. Apply clinically with caution. Great talk by Wayne Brisbane. #AUA26
The medical community has a perception that breast cancer screening GOOD and prostate cancer screening BAD. Internist Gil Welch provides data showing just how flawed that perception is.
Congratulations to @liquidgoldwayne for @ISSM_INFO lifetime achievement award.
For the @yoursexmedjour special issue on “prosthetic urology” that Dr. Hellstrom edited 👉🏻 https://t.co/NFJWdfjS3Z
Something I’ve never shared publicly before.
Early in residency, I placed a “simple" suprapubic tube. It went fine. Then my patient died.
I nearly walked away from surgery forever.
Turns out residency never ends. The doubt, the what-ifs, the crushing weight of decisions… they follow you your whole career.
Here’s how I’ve learned to carry it anyway:
https://t.co/FXwGDmiuxx
@AmerUrological #MedTwitter #Surgery
https://t.co/u1cnxZAxj9
US News voting has started. Check out all the amazing things happening here at HUMC urology. If you are a board certified urologist please consider casting 1 of your 5 votes for us through Doximity.
IT IS THIS TIME OF THE YEAR AGAIN!
TOP 10 GU clinical trials in 2025!
1/ Practice-changing IMvigor011: In ctDNA+ MIBC post-cystectomy, adjuvant atezo improved DFS (HR 0.64) & OS (HR 0.59) vs placebo. ctDNA- pts spared therapy w/ 2-yr DFS ~88%.
@tompowles1@DrYukselUrun@OncoBellmunt@NEJM #ESMO2025 Plenary @myESMO
https://t.co/mbl2VKLZ2N
Celebrated @HUMCUrology’s many accomplishments at our annual symposium last night. Our panelists shared their important work abroad building foundations to improve global surgery. Honorary speaker Harry Carson inspired us all with his story of prostate cancer dx and txt at HUMC.
DECAF trial: continued consumption of caffeinated coffee was associated with a 39% lower risk of AF/AFL recurrence at 6 months after cardioversion vs. abstinence from coffee. View the slides here: https://t.co/zHib2T5gL0